{ "company_number": "10612687", "name": "Ridge Pharma Limited", "url": "/company/10612687", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2017-02-10", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 176423, "url": "/address/176423", "line1": "12 PARK LANE", "line2": "TILEHURST", "post_town": "READING", "county": "BERKSHIRE", "country": "ENGLAND", "postcode": "RG31 5DL" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10612687", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-09-30", "last_made_up": "2025-12-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/10612687/accounts/2025-12-31", "pdf_url": "/company/10612687/accounts/2025-12-31.pdf", "made_up_date": "2025-12-31", "period_start": "2025-01-01", "period_end": "2025-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "22.00", "tangible_fixed_assets": "15535.00", "debtors": "873954.00", "cash_bank_in_hand": "410729.00", "current_assets": "2711846.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "253973.00", "total_assets_less_current_liabilities": "269508.00", "net_assets_liabilities": "539882.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2196.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-125621.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-09-23.zip" }, { "url": "/company/10612687/accounts/2024-12-31", "pdf_url": "/company/10612687/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-01-01", "period_end": "2024-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "22.00", "tangible_fixed_assets": "17379.00", "debtors": "657749.00", "cash_bank_in_hand": "477530.00", "current_assets": "2609951.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "506253.00", "total_assets_less_current_liabilities": "523632.00", "net_assets_liabilities": "665503.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2196.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-36157.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2025.zip" }, { "url": "/company/10612687/accounts/2023-12-31", "pdf_url": "/company/10612687/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-12-31", "period_end": "2023-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "21.00", "tangible_fixed_assets": "14238.00", "debtors": "716849.00", "cash_bank_in_hand": "534917.00", "current_assets": "2185603.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "574292.00", "total_assets_less_current_liabilities": "588530.00", "net_assets_liabilities": "701660.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "701660.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2024.zip" }, { "url": "/company/10612687/accounts/2022-12-31", "pdf_url": "/company/10612687/accounts/2022-12-31.pdf", "made_up_date": "2022-12-31", "period_start": "2022-01-01", "period_end": "2022-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "13.00", "tangible_fixed_assets": "11887.00", "debtors": "398154.00", "cash_bank_in_hand": "108344.00", "current_assets": "1353585.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "792378.00", "total_assets_less_current_liabilities": "804265.00", "net_assets_liabilities": "886606.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2196.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-394517.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2023.zip" }, { "url": "/company/10612687/accounts/2021-12-31", "pdf_url": "/company/10612687/accounts/2021-12-31.pdf", "made_up_date": "2021-12-31", "period_start": "2021-01-01", "period_end": "2021-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "11741.00", "debtors": "443793.00", "cash_bank_in_hand": "578165.00", "current_assets": "1761915.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1203900.00", "total_assets_less_current_liabilities": "1215641.00", "net_assets_liabilities": "1281123.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2196.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-500987.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2022.zip" }, { "url": "/company/10612687/accounts/2020-12-31", "pdf_url": "/company/10612687/accounts/2020-12-31.pdf", "made_up_date": "2020-12-31", "period_start": "2020-01-01", "period_end": "2020-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "7584.00", "debtors": "326758.00", "cash_bank_in_hand": "927670.00", "current_assets": "1825621.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1668232.00", "total_assets_less_current_liabilities": "1675816.00", "net_assets_liabilities": "1782110.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2196.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-836423.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2021.zip" }, { "url": "/company/10612687/accounts/2019-12-31", "pdf_url": "/company/10612687/accounts/2019-12-31.pdf", "made_up_date": "2019-12-31", "period_start": "2019-01-01", "period_end": "2019-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "5715.00", "debtors": "194080.00", "cash_bank_in_hand": "800670.00", "current_assets": "1456585.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1259909.00", "total_assets_less_current_liabilities": "1265624.00", "net_assets_liabilities": "1414560.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1858.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-1297687.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2020.zip" }, { "url": "/company/10612687/accounts/2018-12-31", "pdf_url": "/company/10612687/accounts/2018-12-31.pdf", "made_up_date": "2018-12-31", "period_start": "2018-12-31", "period_end": "2018-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "3776.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "2388380.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2708471.00", "total_assets_less_current_liabilities": "2712247.00", "net_assets_liabilities": "2712247.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2712247.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2019.zip" }, { "url": "/company/10612687/accounts/2017-12-31", "pdf_url": "/company/10612687/accounts/2017-12-31.pdf", "made_up_date": "2017-12-31", "period_start": "2017-12-31", "period_end": "2017-12-31", "entity_name": "Ridge Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "575.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "248260.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-37694.00", "total_assets_less_current_liabilities": "-37119.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-37119.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2018.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10612687/filing-history" }, "confirmation_statement": { "next_due": "2027-02-03", "last_made_up": "2026-01-20" }, "officers": [ { "name": "MCEWAN, Brian Alexander", "person_url": "/person/6062253", "role": "director", "appointed_on": "2020-10-22", "resigned_on": "2026-07-16", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-17T04:16:02+00:00" }, { "name": "STRATFORD, Harry Thomas", "person_url": "/person/6062255", "role": "director", "appointed_on": "2017-06-23", "resigned_on": "2026-07-16", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-17T04:17:02+00:00" } ], "psc": [ { "name": "Mercia Fund Management Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/06973399", "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2022-09-13", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Nvm Private Equity Llp", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/OC392261", "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2018-09-04", "ceased_on": "2022-09-13", "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Mrs Caroline Stratford", "kind": "individual-person-with-significant-control", "person_url": "/person/780558", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2018-07-23", "ceased_on": "2018-08-08", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Harry Thomas Stratford", "kind": "individual-person-with-significant-control", "person_url": "/person/1853687", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2018-07-23", "ceased_on": "2018-08-08", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-10-01", "retrieved_at": "2026-10-04T03:24:57.345227+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }